• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    •   ScholarShip Home
    • Other Campus Research
    • Open Access
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)

    Thumbnail
    View/ Open
    1471-2172-12-72.pdf (2.232Mb)

    Show full item record
    
    Author
    Abbott, Derek J; Blanchfield, J Lori; Martinson, David A; Russell, Sean C; Taslim, Najla; Curtis, Alan D; Mannie, Mark D
    Abstract
    BACKGROUND: Vaccination strategies that elicit antigen-specific tolerance are needed as therapies for autoimmune disease. This study focused on whether cytokine-neuroantigen (NAg) fusion proteins could inhibit disease in chronic murine models of experimental autoimmune encephalomyelitis (EAE) and thus serve as potential therapeutic modalities for multiple sclerosis. RESULTS: A fusion protein comprised of murine GM-CSF as the N-terminal domain and the encephalitogenic MOG35-55 peptide as the C-terminal domain was tested as a tolerogenic, therapeutic vaccine (TTV) in the C57BL/6 model of EAE. Administration of GMCSF-MOG before active induction of EAE, or alternatively, at the onset of EAE blocked the development and progression of EAE. Covalent linkage of the GM-CSF and MOG35-55 domains was required for tolerogenic activity. Likewise, a TTV comprised of GM-CSF and PLP139-151 was a tolerogen in the SJL model of EAE. CONCLUSION: These data indicated that fusion proteins containing GM-CSF coupled to myelin auto-antigens elicit tolerance rather than immunity.
    URI
    http://hdl.handle.net/10342/7744
    Date
    2011-12-30
    Citation:
    APA:
    Abbott, Derek J, & Blanchfield, J Lori, & Martinson, David A, & Russell, Sean C, & Taslim, Najla, & Curtis, Alan D, & Mannie, Mark D. (December 2011). Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). BMC Immunology, (12:72), p.1-18. Retrieved from http://hdl.handle.net/10342/7744

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    Abbott, Derek J, and Blanchfield, J Lori, and Martinson, David A, and Russell, Sean C, and Taslim, Najla, and Curtis, Alan D, and Mannie, Mark D. "Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)". BMC Immunology. 12:72. (1-18.), December 2011. March 03, 2021. http://hdl.handle.net/10342/7744.
    Chicago:
    Abbott, Derek J and Blanchfield, J Lori and Martinson, David A and Russell, Sean C and Taslim, Najla and Curtis, Alan D and Mannie, Mark D, "Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE)," BMC Immunology 12, no. 72 (December 2011), http://hdl.handle.net/10342/7744 (accessed March 03, 2021).
    AMA:
    Abbott, Derek J, Blanchfield, J Lori, Martinson, David A, Russell, Sean C, Taslim, Najla, Curtis, Alan D, Mannie, Mark D. Neuroantigen-specific, tolerogenic vaccines: GM-CSF is a fusion partner that facilitates tolerance rather than immunity to dominant self-epitopes of myelin in murine models of experimental autoimmune encephalomyelitis (EAE). BMC Immunology. December 2011; 12(72) 1-18. http://hdl.handle.net/10342/7744. Accessed March 03, 2021.
    Collections
    • Open Access

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback